Healthcare Giant Johnson & Johnson Surges Past 664 Billion Valuation

New Brunswick, Monday, 9 November 2026.
Shares rose 1.43 percent as market value topped $664 billion, bolstered by key drug approvals and strong institutional support that reinforced the company’s defensive strength amid market volatility.